Find the right Medicare plan for 2026 — compare coverage and costs in minutes.

Compare Medicare Plans →
Industry News Healthcare News

40 percent report buying less produce amid cyclospora outbreak: Poll

A poll released Sunday shows that 40 percent of U.S. adults are buying or eating less produce after the cyclospora outbreak. Comparatively, according to survey results from CBS/YouGov, 4 percent of people said they are eating more produce. Among respondents, 56 percent said there has been no change in their diet. Earlier this month, the...

Read full article →
Industry News Healthcare News

Top Democrat calls on Taylor Farms to provide information on Trump administration cyclospora communications

Rep. Robert Garcia (D-Calif.), the ranking member of the House Oversight and Government Reform Committee, on Monday called on Taylor Farms to provide information about its connections with the White House amid a parasitic outbreak potentially linked to the company's lettuce supply. Garcia wrote a letter to Taylor Farms CEO Bruce Taylor questioning whether the...

Read full article →
Senior Health MedPageToday.com - medical news for physicians

Effort to Unionize 10,000 Attending Physicians Gets Underway

(MedPage Today) -- Some doctors are pushing to organize the 10,000 attending physicians within the University of California system, setting in motion what could become the largest union of employed physicians, organizers say. Factors driving the...

Read full article →
Senior Health MedPageToday.com - medical news for physicians

FDA Approves New Blood Test for Colon Cancer Screening

(MedPage Today) -- The FDA approved SimpleScreen CRC, a blood-based screening test for adults 45 years and older who are at average risk for colorectal cancer (CRC), Freenome announced. SimpleScreen CRC joins Guardant Health's Shield test, which...

Read full article →
Senior Health MedPageToday.com - medical news for physicians

What Is the 'Barbie Peptide' and Why Is It Risky?

(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. An unregulated injectable peptide popping up across social media promises...

Read full article →
Senior Health MedPageToday.com - medical news for physicians

First-in-Class Drug for ADHD Wins FDA Approval

(MedPage Today) -- The FDA approved oral centanafadine (Simtriyo), a first-in-class triple reuptake inhibitor for attention deficit-hyperactivity disorder (ADHD), Otsuka announced late last week. The once-daily extended-release capsule -- a...

Read full article →